PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
HCM vs. BRK-B
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HCM and BRK-B is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

HCM vs. BRK-B

Last updated May 31, 2025

Compare and contrast key facts about HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HCM or BRK-B.

Performance

HCM vs. BRK-B - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HCM:

-0.45

BRK-B:

1.19

Sortino Ratio

HCM:

-0.38

BRK-B:

1.77

Omega Ratio

HCM:

0.96

BRK-B:

1.25

Calmar Ratio

HCM:

-0.38

BRK-B:

2.81

Martin Ratio

HCM:

-1.17

BRK-B:

6.66

Ulcer Index

HCM:

23.52%

BRK-B:

3.72%

Daily Std Dev

HCM:

58.77%

BRK-B:

19.76%

Max Drawdown

HCM:

-82.18%

BRK-B:

-53.86%

Current Drawdown

HCM:

-67.65%

BRK-B:

-6.64%

Fundamentals

Market Cap

HCM:

$2.37B

BRK-B:

$1.09T

EPS

HCM:

$0.20

BRK-B:

$37.51

PE Ratio

HCM:

69.30

BRK-B:

13.49

PEG Ratio

HCM:

0.00

BRK-B:

10.06

PS Ratio

HCM:

3.76

BRK-B:

2.94

PB Ratio

HCM:

3.12

BRK-B:

1.67

Total Revenue (TTM)

HCM:

$477.36M

BRK-B:

$395.26B

Gross Profit (TTM)

HCM:

$6.44M

BRK-B:

$317.24B

EBITDA (TTM)

HCM:

-$20.73M

BRK-B:

$115.24B

Returns By Period

In the year-to-date period, HCM achieves a -3.61% return, which is significantly lower than BRK-B's 11.18% return.

HCM

YTD

-3.61%

1M

-6.46%

6M

-18.05%

1Y

-26.31%

3Y*

9.71%

5Y*

-8.63%

10Y*

N/A

BRK-B

YTD

11.18%

1M

-5.49%

6M

4.34%

1Y

23.34%

3Y*

16.84%

5Y*

22.12%

10Y*

13.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

HUTCHMED (China) Limited

Berkshire Hathaway Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

HCM vs. BRK-B — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
HCM
The Risk-Adjusted Performance Rank of HCM is 2424
Overall Rank
The Sharpe Ratio Rank of HCM is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of HCM is 2525
Sortino Ratio Rank
The Omega Ratio Rank of HCM is 2626
Omega Ratio Rank
The Calmar Ratio Rank of HCM is 2626
Calmar Ratio Rank
The Martin Ratio Rank of HCM is 1919
Martin Ratio Rank
BRK-B
The Risk-Adjusted Performance Rank of BRK-B is 8787
Overall Rank
The Sharpe Ratio Rank of BRK-B is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of BRK-B is 8282
Sortino Ratio Rank
The Omega Ratio Rank of BRK-B is 8383
Omega Ratio Rank
The Calmar Ratio Rank of BRK-B is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BRK-B is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HCM vs. BRK-B - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current HCM Sharpe Ratio is -0.45, which is lower than the BRK-B Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of HCM and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

HCM vs. BRK-B - Dividend Comparison

Neither HCM nor BRK-B has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

HCM vs. BRK-B - Drawdown Comparison

The maximum HCM drawdown since its inception was -82.18%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for HCM and BRK-B.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

HCM vs. BRK-B - Volatility Comparison

HUTCHMED (China) Limited (HCM) has a higher volatility of 9.52% compared to Berkshire Hathaway Inc. (BRK-B) at 6.63%. This indicates that HCM's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

HCM vs. BRK-B - Financials Comparison

This section allows you to compare key financial metrics between HUTCHMED (China) Limited and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.0050.00B100.00B150.00B20212022202320242025
162.26M
83.29B
(HCM) Total Revenue
(BRK-B) Total Revenue
Values in USD except per share items